CObalt chromium STent with Antiproliferation for Restenosis II Trial

ID Number 05-1305

Principal Investigator(s)
Samin K Sharma

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this study is to demonstrate the efficacy of Costar Paclitaxel-Eluting Coronary Stent (investigational device) system compared to TAXUSTM Express2TM Drug Eluting Coronary Stent System.

Contact Information
Kameswari Vallabhajosyula NA
(212) 241-5696

Recruiting Patients: No